Active, Not Recruiting
A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
NCT04111458
- Conditions
- Solid Tumors, KRAS Mutation; SOS1
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Levine Cancer Institute Charlotte, North Carolina, United States
- Sarah Cannon Research Institute-Nashville-48456 Nashville, Tennessee, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States